Olympus (China) Co., Ltd.
In 1949, Olympus Optical Industry was commissioned by doctors from the Affiliated Hospital of the University of Tokyo in Japan to develop a "camera that can photograph the inside of a patient's stomach", which was later the "stomach camera". With Olympus' technical accumulation in the field of optical, a series of repeated experiments, including the production of micro lenses, the discussion of strong light sources, the exploration of main soft pipes, the selection of appropriate films, and the research of waterproofing measures, have been carried out one after another. In 1950, after all the difficulties that were difficult to describe, a stomach camera was created. It is generally recognized by the medical community that endoscopy is the "gold standard" for gastrointestinal cancer detection. Modern endoscopic technology is different now, and the pain caused by endoscopic testing to patients has been greatly reduced. Olympus' capsule endoscopy for small intestine examination has also been put into clinical use, achieving simple and painless internal diagnosis of the small intestine.
Olympus (China) Co., Ltd.
In 1949, Olympus Optical Industry was commissioned by doctors from the Affiliated Hospital of the University of Tokyo in Japan to develop a "camera that can photograph the inside of a patient's stomach", which was later the "stomach camera". With Olympus' technical accumulation in the field of optical, a series of repeated experiments, including the production of micro lenses, the discussion of strong light sources, the exploration of main soft pipes, the selection of appropriate films, and the research of waterproofing measures, have been carried out one after another. In 1950, after all the difficulties that were difficult to describe, a stomach camera was created. It is generally recognized by the medical community that endoscopy is the "gold standard" for gastrointestinal cancer detection. Modern endoscopic technology is different now, and the pain caused by endoscopic testing to patients has been greatly reduced. Olympus' capsule endoscopy for small intestine examination has also been put into clinical use, achieving simple and painless internal diagnosis of the small intestine.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medical Electronics Co., Ltd.
Shenzhen Kaili Biomedical Technology Co., Ltd. (stock code: 300633) is a global advanced technology company dedicated to the independent research and development and manufacturing of medical equipment, covering ultrasound medical imaging, endoscopic diagnosis and treatment, minimally invasive surgery and cardiovascular intervention. In the field, it provides professional and specialized overall solutions for medical institutions in more than 170 countries and regions around the world. Kaili Medical is determined to become a technological force to protect global health and create more possibilities for life.
Medical Electronics Co., Ltd.
Shenzhen Kaili Biomedical Technology Co., Ltd. (stock code: 300633) is a global advanced technology company dedicated to the independent research and development and manufacturing of medical equipment, covering ultrasound medical imaging, endoscopic diagnosis and treatment, minimally invasive surgery and cardiovascular intervention. In the field, it provides professional and specialized overall solutions for medical institutions in more than 170 countries and regions around the world. Kaili Medical is determined to become a technological force to protect global health and create more possibilities for life.
AnHui Medical Technology (Wuhan) Co., Ltd.
Anhan Technology was founded in 2009 and is a high-tech enterprise focusing on the research, development, production and operation of innovative medical devices in the field of digestive tract health. The company focuses on international cutting-edge medical technology innovation and is the pioneer and pioneer of magnetron capsule gastroscopy technology. It is committed to promoting comfortable and precise premature screening of digestive tract diseases, and opens up an intelligent health management platform for the prevention of digestive tract diseases. The closed loop of screening, diagnosis, treatment and health helps a healthy China. Anhan Technology's gastrointestinal disease screening products ( Anhan "magnet-controlled capsule gastroscopy system" ) and constipation treatment products (Vibra Bot™ "digestive tract vibration capsule system") provide new ideas for world medical technology. Among them, the "magnetically controlled capsule gastroscopy system" has achieved comfortable stomach accuracy examination of "no intubation and gastroscopy", and obtained the registration certificate of the third category of medical device of the "magnetically controlled capsule gastroscopy system" issued by the State Food and Drug Administration and the EU CE certification and passed the US De Novo FDA innovative medical device registration. At present, this product has been clinically used in nearly 1,000 medical institutions in 31 provinces, cities and autonomous regions across the country, and has been sold to overseas markets. Clinical studies have shown that the accuracy of Anhan's "magnet-controlled capsule gastroscopy system" for gastric diseases is highly consistent with that of electronic gastroscopy. Its comfortable examination method effectively solves the pain point of people's gastroscopy "dare not to check, are unwilling to check, and cannot check" and is especially suitable for asymptomatic people to have gastric physical examinations and improves the detection rate of early gastric cancer in China. With the massive growth of clinical data, the integration of AI technology, and the development of interdisciplinary research, Anhan's "Magnet-controlled capsule gastroscopy system" application department has been continuously expanded, covering gastrointestinal department, physical examination department, cardiology, geriatric department, pediatric department, and emergency diagnosis. and other disciplines. Among them, clinical research that penetrates the Department of Cardiology and Gastroenterology has created a new era of cross-disciplinary cross-section and precise prevention and control of digestive tract bleeding after intracardiac PCl surgery. As an innovative medical device product used in constipation treatment, Anhan's "Gastronomical Vibration Capsule System" (VibraBot™), has ushered in a new era of pure physical treatment of constipation. This product is based on the theory of physical nerve stimulation, promotes intestinal peristalsis through massage, solves constipation problems, and has obtained the innovative medical device registration certificate (class III medical devices) issued by the State Food and Drug Administration. Currently, no similar products are on the market at home and abroad. Technological innovation is the foundation of Anhan. At present, Anhan Technology has more than 300 authorized patents at home and abroad, of which invention patents account for as much as 40%, and its R&D strength demonstrates the true nature of science and technology innovation. As a model of integration of medicine and engineering, Anhan products have always been a hot topic in clinical research. A large number of landmark evidence-based research results have been published in international academic journals. Relying on artificial intelligence and 5G technology, Anhan Technology has innovatively launched the "magnet-controlled capsule gastroscopy mobile examination vehicle", realizing mobile examination of gastroscopy and online remote consultation, effectively allocating medical resources and promoting the "center of gravity to the screening of gastrointestinal tumors. ” and “shift forward”. Combined with Internet + medical care, Anhan Technology's closed-loop full-gastrointestinal health management platform for "preventing serious diseases, managing chronic diseases, and promoting health" has taken shape. Technology makes life healthier. In the future, Anhan Technology will continue to take protecting the health of the digestive tract of the people as its mission, continuously enrich the product structure in the field of digestive tract health, promote the high-quality development of domestic medical devices, and create an intelligent full-gastrointestinal health management platform to better serve health. Life, protect a healthy China!
AnHui Medical Technology (Wuhan) Co., Ltd.
Anhan Technology was founded in 2009 and is a high-tech enterprise focusing on the research, development, production and operation of innovative medical devices in the field of digestive tract health. The company focuses on international cutting-edge medical technology innovation and is the pioneer and pioneer of magnetron capsule gastroscopy technology. It is committed to promoting comfortable and precise premature screening of digestive tract diseases, and opens up an intelligent health management platform for the prevention of digestive tract diseases. The closed loop of screening, diagnosis, treatment and health helps a healthy China. Anhan Technology's gastrointestinal disease screening products ( Anhan "magnet-controlled capsule gastroscopy system" ) and constipation treatment products (Vibra Bot™ "digestive tract vibration capsule system") provide new ideas for world medical technology. Among them, the "magnetically controlled capsule gastroscopy system" has achieved comfortable stomach accuracy examination of "no intubation and gastroscopy", and obtained the registration certificate of the third category of medical device of the "magnetically controlled capsule gastroscopy system" issued by the State Food and Drug Administration and the EU CE certification and passed the US De Novo FDA innovative medical device registration. At present, this product has been clinically used in nearly 1,000 medical institutions in 31 provinces, cities and autonomous regions across the country, and has been sold to overseas markets. Clinical studies have shown that the accuracy of Anhan's "magnet-controlled capsule gastroscopy system" for gastric diseases is highly consistent with that of electronic gastroscopy. Its comfortable examination method effectively solves the pain point of people's gastroscopy "dare not to check, are unwilling to check, and cannot check" and is especially suitable for asymptomatic people to have gastric physical examinations and improves the detection rate of early gastric cancer in China. With the massive growth of clinical data, the integration of AI technology, and the development of interdisciplinary research, Anhan's "Magnet-controlled capsule gastroscopy system" application department has been continuously expanded, covering gastrointestinal department, physical examination department, cardiology, geriatric department, pediatric department, and emergency diagnosis. and other disciplines. Among them, clinical research that penetrates the Department of Cardiology and Gastroenterology has created a new era of cross-disciplinary cross-section and precise prevention and control of digestive tract bleeding after intracardiac PCl surgery. As an innovative medical device product used in constipation treatment, Anhan's "Gastronomical Vibration Capsule System" (VibraBot™), has ushered in a new era of pure physical treatment of constipation. This product is based on the theory of physical nerve stimulation, promotes intestinal peristalsis through massage, solves constipation problems, and has obtained the innovative medical device registration certificate (class III medical devices) issued by the State Food and Drug Administration. Currently, no similar products are on the market at home and abroad. Technological innovation is the foundation of Anhan. At present, Anhan Technology has more than 300 authorized patents at home and abroad, of which invention patents account for as much as 40%, and its R&D strength demonstrates the true nature of science and technology innovation. As a model of integration of medicine and engineering, Anhan products have always been a hot topic in clinical research. A large number of landmark evidence-based research results have been published in international academic journals. Relying on artificial intelligence and 5G technology, Anhan Technology has innovatively launched the "magnet-controlled capsule gastroscopy mobile examination vehicle", realizing mobile examination of gastroscopy and online remote consultation, effectively allocating medical resources and promoting the "center of gravity to the screening of gastrointestinal tumors. ” and “shift forward”. Combined with Internet + medical care, Anhan Technology's closed-loop full-gastrointestinal health management platform for "preventing serious diseases, managing chronic diseases, and promoting health" has taken shape. Technology makes life healthier. In the future, Anhan Technology will continue to take protecting the health of the digestive tract of the people as its mission, continuously enrich the product structure in the field of digestive tract health, promote the high-quality development of domestic medical devices, and create an intelligent full-gastrointestinal health management platform to better serve health. Life, protect a healthy China!
Shenzhen Aimida Medical Technology Co., Ltd.
Shenzhen InnerMedical Technology Co., Ltd. was established in 2015 and aims to provide high-quality and innovative diagnostic and treatment solutions for clinical practice. Currently, it focuses on digestive tract/respiratory tract tumors and cardiovascular diseases. Through continuous technological innovation, it has completed the launch of endoscopic ultrasound diagnostic equipment, high-definition electronic endoscopy and medical image processing software platforms; it has opened up the internationally leading intravascular system A series of product solutions such as dual-mode imaging systems will continue to develop and optimize products and services to improve patients' medical quality and diagnosis and treatment experience. The company attaches great importance to R&D and has built multiple technical platforms such as ultrasonic electronics, optical technology, energy technology, and interventional equipment, involving more than 20 technical sub-directions. The company has built a production and R&D site that meets the requirements of GMP and ISO13485, with a complete and international standard quality assurance.
Shenzhen Aimida Medical Technology Co., Ltd.
Shenzhen InnerMedical Technology Co., Ltd. was established in 2015 and aims to provide high-quality and innovative diagnostic and treatment solutions for clinical practice. Currently, it focuses on digestive tract/respiratory tract tumors and cardiovascular diseases. Through continuous technological innovation, it has completed the launch of endoscopic ultrasound diagnostic equipment, high-definition electronic endoscopy and medical image processing software platforms; it has opened up the internationally leading intravascular system A series of product solutions such as dual-mode imaging systems will continue to develop and optimize products and services to improve patients' medical quality and diagnosis and treatment experience. The company attaches great importance to R&D and has built multiple technical platforms such as ultrasonic electronics, optical technology, energy technology, and interventional equipment, involving more than 20 technical sub-directions. The company has built a production and R&D site that meets the requirements of GMP and ISO13485, with a complete and international standard quality assurance.
Pentax Medical (Shanghai) Co., Ltd.
PENTAXMedical is a branch of the HOYA Group that provides endoscopic imaging solutions and is a diversified multinational company with research and development innovation and manufacturing centers in Japan, Europe and the United States. Pentax Medical was founded in Japan in 1919 and was originally named Asahi Optical Co., Ltd. In 1970, Pentax Medical was listed on the Tokyo Stock Exchange. In 1977, he started to open branches in Europe and the United States, and since then he embarked on the path of globalization. In 2005, Pentax, the United States acquired Kay Elemetrics. 2008 HOYACorporation acquired PENTAX. In 2011, HOYA split the Pentax digital cameras, telescopes and other businesses to Ricoh RICHO, retaining core businesses such as endoscopes and artificial bones. Both parties share the Pentax trademark. In 2011, Pentax Medical (Shanghai) Co., Ltd. was established to set up its layout in Asia. In 2012, HOYA acquired Digital Endoscopy GmbH, a digital endoscope company. In 2013, HOYA Heuer Group and Wassenburg Medical Devices established a joint venture in the field of endoscopy. In 2015, Pentax Medical invested in Creo Medical Co., Ltd. In 2017, Pentax Medical acquired C2Therapeutics, which owns CryoBalloon ablation technology for the treatment of Barrett's esophageal and squamous dysplasia.
Pentax Medical (Shanghai) Co., Ltd.
PENTAXMedical is a branch of the HOYA Group that provides endoscopic imaging solutions and is a diversified multinational company with research and development innovation and manufacturing centers in Japan, Europe and the United States. Pentax Medical was founded in Japan in 1919 and was originally named Asahi Optical Co., Ltd. In 1970, Pentax Medical was listed on the Tokyo Stock Exchange. In 1977, he started to open branches in Europe and the United States, and since then he embarked on the path of globalization. In 2005, Pentax, the United States acquired Kay Elemetrics. 2008 HOYACorporation acquired PENTAX. In 2011, HOYA split the Pentax digital cameras, telescopes and other businesses to Ricoh RICHO, retaining core businesses such as endoscopes and artificial bones. Both parties share the Pentax trademark. In 2011, Pentax Medical (Shanghai) Co., Ltd. was established to set up its layout in Asia. In 2012, HOYA acquired Digital Endoscopy GmbH, a digital endoscope company. In 2013, HOYA Heuer Group and Wassenburg Medical Devices established a joint venture in the field of endoscopy. In 2015, Pentax Medical invested in Creo Medical Co., Ltd. In 2017, Pentax Medical acquired C2Therapeutics, which owns CryoBalloon ablation technology for the treatment of Barrett's esophageal and squamous dysplasia.
Shenzhen Zifu Medical Technology Co., Ltd.
Shenzhen Zifu Medical Technology Co., Ltd. was founded in 2011. It is a national high-tech enterprise focusing on the research, development, production, sales and service of gastrointestinal medical products. The company is headquartered in the High-tech Industrial Park, Nanshan District, Shenzhen, and has set up a modern production base in Shenzhen Guangming. The company has established a medical device quality management system, passed the medical device production quality management specification (GMP) inspection and ISO13485 quality management system certification. The company has built a professional R&D team and an international R&D management platform, and has undertaken a number of technological innovation projects in the country and Shenzhen, and has obtained more than 100 national patents. The "Da Sheng" magnetron capsule endoscope system series products that adhere to independent innovation and uphold the spirit of craftsmanship have been independently developed for ten years. They have obtained the NMPA Class III medical device registration and EU CE certification (EC certification) of the National Medical Products Administration. , widely praised by medical institutions. The company has always adhered to the quality policy of "using professional technology, scientific processes, research and development of innovative products, and providing customers with safe and effective medical and health products and services". It is determined to become a respected century-old medical enterprise and continue to serve human beings. Contribute to the health cause.
Shenzhen Zifu Medical Technology Co., Ltd.
Shenzhen Zifu Medical Technology Co., Ltd. was founded in 2011. It is a national high-tech enterprise focusing on the research, development, production, sales and service of gastrointestinal medical products. The company is headquartered in the High-tech Industrial Park, Nanshan District, Shenzhen, and has set up a modern production base in Shenzhen Guangming. The company has established a medical device quality management system, passed the medical device production quality management specification (GMP) inspection and ISO13485 quality management system certification. The company has built a professional R&D team and an international R&D management platform, and has undertaken a number of technological innovation projects in the country and Shenzhen, and has obtained more than 100 national patents. The "Da Sheng" magnetron capsule endoscope system series products that adhere to independent innovation and uphold the spirit of craftsmanship have been independently developed for ten years. They have obtained the NMPA Class III medical device registration and EU CE certification (EC certification) of the National Medical Products Administration. , widely praised by medical institutions. The company has always adhered to the quality policy of "using professional technology, scientific processes, research and development of innovative products, and providing customers with safe and effective medical and health products and services". It is determined to become a respected century-old medical enterprise and continue to serve human beings. Contribute to the health cause.
Chongqing Jinshan Science & Technology Group Co., Ltd.
Chongqing Jinshan Technology Group Co., Ltd. was established in 1998. It is a national high-tech enterprise integrating the research and development, production, sales and service of digital medical equipment. The company has established the "Academician Workstation" and "Doctoral Workstation" with the micro system MEMS technology as the core, and has received support from many experts. It has successively undertaken dozens of national-level "863 Plan", national science and technology research plan, international cooperation plan and other national-level cooperation plan. The scientific research plan has dozens of medical device products, including capsule endoscopy, pH capsule, esophageal impedance-pH joint monitoring system, uterine cavity observation and attraction surgery system (gynecology), impedance CT, etc. The company's products and solutions have been widely used in more than 80 countries and regions including Spain, Italy, the United Kingdom, Germany, Russia, Canada, India, etc. The company takes it as its mission to protect people's health, insists on independent innovation, and continues to develop "minimally invasive, disposable, intelligent, integrated and networked" high-tech medical devices, in medical imaging, biochemical testing, active implantable interventional devices, and remote Research has been carried out extensively in the fields of medical information management.
Chongqing Jinshan Science & Technology Group Co., Ltd.
Chongqing Jinshan Technology Group Co., Ltd. was established in 1998. It is a national high-tech enterprise integrating the research and development, production, sales and service of digital medical equipment. The company has established the "Academician Workstation" and "Doctoral Workstation" with the micro system MEMS technology as the core, and has received support from many experts. It has successively undertaken dozens of national-level "863 Plan", national science and technology research plan, international cooperation plan and other national-level cooperation plan. The scientific research plan has dozens of medical device products, including capsule endoscopy, pH capsule, esophageal impedance-pH joint monitoring system, uterine cavity observation and attraction surgery system (gynecology), impedance CT, etc. The company's products and solutions have been widely used in more than 80 countries and regions including Spain, Italy, the United Kingdom, Germany, Russia, Canada, India, etc. The company takes it as its mission to protect people's health, insists on independent innovation, and continues to develop "minimally invasive, disposable, intelligent, integrated and networked" high-tech medical devices, in medical imaging, biochemical testing, active implantable interventional devices, and remote Research has been carried out extensively in the fields of medical information management.
Wolf Medical Device Trading (Taicang) Co., Ltd.
Richard Wolf Germany Co., Ltd. offers a variety of products and systems for endoscopy and external shock wave therapy. The equipment provided by the company involves almost all specialized disciplines in human medicine. As an auxiliary, the product series is also equipped with an operating room management system called core nova. The core nova system can relieve the burden of operating room staff from performing organizational management, making the system equally suitable for hospitals and medical clinics. Industrial endoscopes make existing equipment products more perfect.
Wolf Medical Device Trading (Taicang) Co., Ltd.
Richard Wolf Germany Co., Ltd. offers a variety of products and systems for endoscopy and external shock wave therapy. The equipment provided by the company involves almost all specialized disciplines in human medicine. As an auxiliary, the product series is also equipped with an operating room management system called core nova. The core nova system can relieve the burden of operating room staff from performing organizational management, making the system equally suitable for hospitals and medical clinics. Industrial endoscopes make existing equipment products more perfect.
Cook Medical Trading (China) Co., Ltd.
Cook Medical is a medical device company from Indiana, USA. It was founded in 1963 by Mr. Bill Cook and his wife. Currently, Cook Medical's business covers 135 countries and regions around the world, with products covering more than 60 professional disciplines, and its production bases are mainly located in the United States, Europe and Australia. It has 6 major logistics distribution centers, multiple local warehousing and distribution centers, as well as more than 10,000 employees worldwide. Since its establishment, Cook Medical has adhered to the operating model of a family business. Unlike listed companies, unique individuality gives full space to consider issues from a long-term perspective, and there is no need to compromise on short-term business interests, truly adhering to the concept, original intention, and realizing the commitment to patients. The company's products have been in the Chinese market for more than 30 years. In 2008, Cook (China) Medical Trading Co., Ltd. was established in Shanghai. Currently, Cook China has two offices in Shanghai and Beijing, of which the Shanghai office is the operation headquarters of Cook China. In the future, Cook Medical will move forward steadily with full enthusiasm and confidence, professional knowledge and rich experience, and provide better products to serve patients and physicians.
Cook Medical Trading (China) Co., Ltd.
Cook Medical is a medical device company from Indiana, USA. It was founded in 1963 by Mr. Bill Cook and his wife. Currently, Cook Medical's business covers 135 countries and regions around the world, with products covering more than 60 professional disciplines, and its production bases are mainly located in the United States, Europe and Australia. It has 6 major logistics distribution centers, multiple local warehousing and distribution centers, as well as more than 10,000 employees worldwide. Since its establishment, Cook Medical has adhered to the operating model of a family business. Unlike listed companies, unique individuality gives full space to consider issues from a long-term perspective, and there is no need to compromise on short-term business interests, truly adhering to the concept, original intention, and realizing the commitment to patients. The company's products have been in the Chinese market for more than 30 years. In 2008, Cook (China) Medical Trading Co., Ltd. was established in Shanghai. Currently, Cook China has two offices in Shanghai and Beijing, of which the Shanghai office is the operation headquarters of Cook China. In the future, Cook Medical will move forward steadily with full enthusiasm and confidence, professional knowledge and rich experience, and provide better products to serve patients and physicians.
Aesculap is a leading global provider of surgical instruments, including bone-cutting tools, known for precision and reliability in medical procedures.
B. Braun Melsungen AG
Aesculap is a leading global provider of surgical instruments, including bone-cutting tools, known for precision and reliability in medical procedures.
Teleflex Medical Device Trading (Shanghai) Co., Ltd.
Teleflex is a global provider of medical technology dedicated to improving people's health and quality of life. Using a goal-driven innovation approach, Teleflex continues to explore unmet clinical needs, providing support to healthcare professionals who are constantly working to create a healthy future. Teleflex’s portfolio offers solutions in vascular access and interventional therapy, surgery, anesthesia, cardiac care, urinary, acute medicine and respiratory care. More than 14,000 Teleflex employees around the world are united and united, believing that what they do every day is of great significance. Teleflex’s brands include Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®.
Teleflex Medical Device Trading (Shanghai) Co., Ltd.
Teleflex is a global provider of medical technology dedicated to improving people's health and quality of life. Using a goal-driven innovation approach, Teleflex continues to explore unmet clinical needs, providing support to healthcare professionals who are constantly working to create a healthy future. Teleflex’s portfolio offers solutions in vascular access and interventional therapy, surgery, anesthesia, cardiac care, urinary, acute medicine and respiratory care. More than 14,000 Teleflex employees around the world are united and united, believing that what they do every day is of great significance. Teleflex’s brands include Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®.
Comerlin Fortec (Beijing) Medical Devices Co., Ltd.
Conmed is a global medical technology company that enables global healthcare providers to provide patients with good solutions through accessible Conmed solutions. For over 50 years, Conmed has provided innovations that impact results for healthcare professionals around the world. Dedicated to helping you improve your results with organic know-how and acquired brands and solutions. Conmed, which dates back to 1970, was founded by Eugene Corasanti in Utica, New York. It was originally called Consolidated Medical Equipment, Inc., focusing mainly on the production of disposable ECG monitoring electrodes. After decades of development, Conmed has become a giant with thousands of products serving the global healthcare field. Conmed's product line covers a variety of specialized areas, including orthopedic surgery, laparoscopy, robotics and open surgery, gastroenterology and pulmonary arts, patient care, and more. Among them, minimally invasive technologies and products in the fields of orthopedics and surgery are particularly prominent, including orthopedic sports medicine solutions, power tool systems, high-frequency electrocution energy systems, 3D and 2D endoscopic systems, and intelligent pneumoresis machine systems. These products are widely used in orthopedics, general surgery, urology, obstetrics and gynecology and other fields, providing strong technical support to doctors. In addition to the richness of the product, Conmed also focuses on R&D and innovation. The company has multiple manufacturing and design facilities, as well as more than 3500 employees, who are committed to designing, producing and marketing innovative high-quality products to improve the quality of healthcare. This persistence in innovation has enabled Conmed to maintain a leading position in the field of medical technology. In addition, Conmed is actively seeking cooperation and acquisitions with other medical technology companies to expand its business scope and enhance its market position. For example, Conmed has acquired In2Bones Global, a company focusing on the development and sale of medical devices for upper and lower limb diseases and injuries. The acquisition further strengthens Conmed's strength in the field of medical technology.
Comerlin Fortec (Beijing) Medical Devices Co., Ltd.
Conmed is a global medical technology company that enables global healthcare providers to provide patients with good solutions through accessible Conmed solutions. For over 50 years, Conmed has provided innovations that impact results for healthcare professionals around the world. Dedicated to helping you improve your results with organic know-how and acquired brands and solutions. Conmed, which dates back to 1970, was founded by Eugene Corasanti in Utica, New York. It was originally called Consolidated Medical Equipment, Inc., focusing mainly on the production of disposable ECG monitoring electrodes. After decades of development, Conmed has become a giant with thousands of products serving the global healthcare field. Conmed's product line covers a variety of specialized areas, including orthopedic surgery, laparoscopy, robotics and open surgery, gastroenterology and pulmonary arts, patient care, and more. Among them, minimally invasive technologies and products in the fields of orthopedics and surgery are particularly prominent, including orthopedic sports medicine solutions, power tool systems, high-frequency electrocution energy systems, 3D and 2D endoscopic systems, and intelligent pneumoresis machine systems. These products are widely used in orthopedics, general surgery, urology, obstetrics and gynecology and other fields, providing strong technical support to doctors. In addition to the richness of the product, Conmed also focuses on R&D and innovation. The company has multiple manufacturing and design facilities, as well as more than 3500 employees, who are committed to designing, producing and marketing innovative high-quality products to improve the quality of healthcare. This persistence in innovation has enabled Conmed to maintain a leading position in the field of medical technology. In addition, Conmed is actively seeking cooperation and acquisitions with other medical technology companies to expand its business scope and enhance its market position. For example, Conmed has acquired In2Bones Global, a company focusing on the development and sale of medical devices for upper and lower limb diseases and injuries. The acquisition further strengthens Conmed's strength in the field of medical technology.
Medigus develops innovative endoscopic devices, including gastroscopes, for minimally invasive diagnostic and therapeutic procedures.
Medigus Ltd.
Medigus develops innovative endoscopic devices, including gastroscopes, for minimally invasive diagnostic and therapeutic procedures.
Karl Storz Endoscopy (Shanghai) Co., Ltd.
Since 1945, Carl Stots has continuously promoted the advancement of medical technology through innovation. From a unknown two-person company in Black Forest, Germany, it has gradually grown into a global leader in the endoscope industry. The family business that has inherited three generations now has 8,800 employees worldwide, with the number of employees at the headquarters alone reaching 3,000. Carl Stots has more than 15,000 human and veterinary medical products for early diagnosis of cancer, minimally invasive surgery, and save patients' lives. Human health and enthusiasm for product innovation are the driving force behind Foshan's continuous progress. The company's products have forward-looking design, excellent craftsmanship and excellent clinical results.
Karl Storz Endoscopy (Shanghai) Co., Ltd.
Since 1945, Carl Stots has continuously promoted the advancement of medical technology through innovation. From a unknown two-person company in Black Forest, Germany, it has gradually grown into a global leader in the endoscope industry. The family business that has inherited three generations now has 8,800 employees worldwide, with the number of employees at the headquarters alone reaching 3,000. Carl Stots has more than 15,000 human and veterinary medical products for early diagnosis of cancer, minimally invasive surgery, and save patients' lives. Human health and enthusiasm for product innovation are the driving force behind Foshan's continuous progress. The company's products have forward-looking design, excellent craftsmanship and excellent clinical results.
Pocos International Medical Trading (Shanghai) Co., Ltd.
Boston Science continues to develop breakthrough medical technologies and products, contributing to the progress of multiple medical fields. Committed to reducing patient trauma, reducing medical costs, and effectively improving the quality of life. Boston Science currently owns more than 13,000 life-improving products, and the company invests more than $1 billion in research and development every year. Boston Science is committed to improving people's lives and improving the health quality of patients around the world through innovative medical solutions. Innovating for life is the mission of Boston Science and a commitment to patients, physicians and medical systems around the world. About 30 million patients benefit from Boston’s scientific innovative medical solutions each year.
Pocos International Medical Trading (Shanghai) Co., Ltd.
Boston Science continues to develop breakthrough medical technologies and products, contributing to the progress of multiple medical fields. Committed to reducing patient trauma, reducing medical costs, and effectively improving the quality of life. Boston Science currently owns more than 13,000 life-improving products, and the company invests more than $1 billion in research and development every year. Boston Science is committed to improving people's lives and improving the health quality of patients around the world through innovative medical solutions. Innovating for life is the mission of Boston Science and a commitment to patients, physicians and medical systems around the world. About 30 million patients benefit from Boston’s scientific innovative medical solutions each year.
Mitutoyo Optical Technology (Shanghai) Co., Ltd.
The Olympus brand was founded in 1919, and in 1921, it independently developed the optical microscope "Xu". For ninety years, Olympus has always been at the forefront of this industry with its core competitiveness of "optical-digital technology", providing precision and professional microscope products to the field of life sciences. With the rapid development of technology, today's microscopes have long bid farewell to the simple optical structure of lenses. The application of microscopes is not limited to observing ordinary chromosomal specimens. With the breakthrough and innovation of Olympus optical technology, various things are more intelligent and more Advanced microscopes have been developed and used to provide reliable support for further exploring the mysteries of life: Olympus FSX100 takes "excellent image", "super simple operation" and "good ergonomic engineering" as its core concepts, and transforms the complexity. In order to simplify, everyone can easily obtain stable and accurate microscope images; the fully built-in laser scanning confocal microscope FV10i obtains a compact structure and a highly stable system through a fully built-in integrated design, making it even more powerful. The complex operation and maintenance of laser confocal microscopes have become history, reflecting the humanized design concept; FV1000-MPE, which has multi-photon laser scanning technology, can deeply observe thick specimens or internal cores of body specimens, and for neuroscience and The research on tissue engineering of artificial organs has had an extremely profound impact, opening a new era of in-depth observation of microscopes. Olympus microscope products have always represented the advanced level of the industry, and are widely used in life sciences and industrial research, and have been well received by users and scientific research institutions. In April 2023, Bain Capital announced that the private equity firm has acquired Evident, former scientific solutions division of Olympus, after obtaining regulatory approval in Japan and other jurisdictions. The Science Division of the Olympus Industrial and Life Sciences business is responsible for Olympus.
Mitutoyo Optical Technology (Shanghai) Co., Ltd.
The Olympus brand was founded in 1919, and in 1921, it independently developed the optical microscope "Xu". For ninety years, Olympus has always been at the forefront of this industry with its core competitiveness of "optical-digital technology", providing precision and professional microscope products to the field of life sciences. With the rapid development of technology, today's microscopes have long bid farewell to the simple optical structure of lenses. The application of microscopes is not limited to observing ordinary chromosomal specimens. With the breakthrough and innovation of Olympus optical technology, various things are more intelligent and more Advanced microscopes have been developed and used to provide reliable support for further exploring the mysteries of life: Olympus FSX100 takes "excellent image", "super simple operation" and "good ergonomic engineering" as its core concepts, and transforms the complexity. In order to simplify, everyone can easily obtain stable and accurate microscope images; the fully built-in laser scanning confocal microscope FV10i obtains a compact structure and a highly stable system through a fully built-in integrated design, making it even more powerful. The complex operation and maintenance of laser confocal microscopes have become history, reflecting the humanized design concept; FV1000-MPE, which has multi-photon laser scanning technology, can deeply observe thick specimens or internal cores of body specimens, and for neuroscience and The research on tissue engineering of artificial organs has had an extremely profound impact, opening a new era of in-depth observation of microscopes. Olympus microscope products have always represented the advanced level of the industry, and are widely used in life sciences and industrial research, and have been well received by users and scientific research institutions. In April 2023, Bain Capital announced that the private equity firm has acquired Evident, former scientific solutions division of Olympus, after obtaining regulatory approval in Japan and other jurisdictions. The Science Division of the Olympus Industrial and Life Sciences business is responsible for Olympus.
Johnson & Johnson (China) Investment Co., Ltd.
Ethicon is a subsidiary of Johnson & Johnson, focusing on the development of innovative laparoscopic products and minimally invasive surgical products. Its business areas cover many aspects such as cardiovascular surgery, general surgery, breast surgery, plastic surgery, spinal surgery, wound suture surgery and ligation. Ethicon has a long history and great contribution in the field of medical devices. Through continuous innovation and research and development, it provides doctors with efficient and precise tools to help patients achieve better treatment results. As part of Johnson & Johnson Medical Devices, Ethicon has made significant contributions to surgery for more than 100 years, from inventing sutures to revolutionizing surgery with minimally invasive surgery. Ethicon's surgical technologies and solutions include sutures, staplers, energy devices, trocars and hemostasis, as well as interventional ablation, robotics and digital solutions. Ethicon has a wide range of product lines, including numerous innovative surgical instruments and suture products. For example, Ethicon has launched synthetic sterile suture Prolene polypropylene suture, which has become the industry standard for cardiac bypass surgery due to its strength, safe ligation and double-matching characteristics. In addition, Ethicon has also launched a revolutionary skin stapler. The introduction of this disposable device makes the operation of the operating room more convenient and efficient. In addition to traditional suture products, Ethicon has developed a series of absorbable sutures with unique advantages. These sutures can be degraded and absorbed by the body after being implanted into human tissue, avoiding the pain of removing the stitches and providing patients with a better surgical experience. At the same time, these absorbable sutures also adopt a unique barb design, making the suture process faster and more efficient, reducing complications related to traditional sutures. In addition to suture products, Ethicon has also achieved success in the field of ultrasonic knives. The HARMONIC ultrasonic knife it produces has been widely recognized in clinical applications, and has the characteristics of large displacement, stable working frequency and moderate working power. Ethicon's ultrasonic knife products are of various types and models, which can meet the needs of different surgeries and provide doctors with efficient and safe surgical tools.
Johnson & Johnson (China) Investment Co., Ltd.
Ethicon is a subsidiary of Johnson & Johnson, focusing on the development of innovative laparoscopic products and minimally invasive surgical products. Its business areas cover many aspects such as cardiovascular surgery, general surgery, breast surgery, plastic surgery, spinal surgery, wound suture surgery and ligation. Ethicon has a long history and great contribution in the field of medical devices. Through continuous innovation and research and development, it provides doctors with efficient and precise tools to help patients achieve better treatment results. As part of Johnson & Johnson Medical Devices, Ethicon has made significant contributions to surgery for more than 100 years, from inventing sutures to revolutionizing surgery with minimally invasive surgery. Ethicon's surgical technologies and solutions include sutures, staplers, energy devices, trocars and hemostasis, as well as interventional ablation, robotics and digital solutions. Ethicon has a wide range of product lines, including numerous innovative surgical instruments and suture products. For example, Ethicon has launched synthetic sterile suture Prolene polypropylene suture, which has become the industry standard for cardiac bypass surgery due to its strength, safe ligation and double-matching characteristics. In addition, Ethicon has also launched a revolutionary skin stapler. The introduction of this disposable device makes the operation of the operating room more convenient and efficient. In addition to traditional suture products, Ethicon has developed a series of absorbable sutures with unique advantages. These sutures can be degraded and absorbed by the body after being implanted into human tissue, avoiding the pain of removing the stitches and providing patients with a better surgical experience. At the same time, these absorbable sutures also adopt a unique barb design, making the suture process faster and more efficient, reducing complications related to traditional sutures. In addition to suture products, Ethicon has also achieved success in the field of ultrasonic knives. The HARMONIC ultrasonic knife it produces has been widely recognized in clinical applications, and has the characteristics of large displacement, stable working frequency and moderate working power. Ethicon's ultrasonic knife products are of various types and models, which can meet the needs of different surgeries and provide doctors with efficient and safe surgical tools.
Stryker (Beijing) Medical Devices Co., Ltd.
As one of the world's cutting-edge medical technology companies, Stryker works sincerely with customers and is committed to improving healthcare. The company provides a range of innovative products and services including plastic surgery, medical and surgical equipment, neurosurgery and spine-related products to help improve the treatment experience of patients and medical institutions. Dr. Homer Stryker, an orthopedic physician in Kalamazoo, Michigan, invented a series of new products after discovering that some medical products cannot meet the needs of patients. There is growing concern and interest in these new medical products, and Dr. Stryker founded The Orthopaedic Frame Company in 1941, specializing in the production of these innovative medical products. In 1942, the company began to build wedge-shaped turnover beds, which allow caregivers to turn over patients with severe back injuries while keeping their spine fixed; In 1946, Stryker founded The Orthopaedic Frame Company; In 1979, the company issued its shares for the first time, bringing more attention to the company; in the same year, Stryker acquired Osteonics Corp. and entered the orthopedic implant market; In 1981, the company's acquisition of SynOptics provided an opportunity to expand into its endoscope business; In 1992, the acquisition of Dimso, SA opened up business opportunities in the field of spinal fixation; In 1996, the acquisition of Osteo SA provided an opportunity to enter the bone trauma market; In 1997, 18 years after the company was listed on the Nasdaq, the company was listed on the New York Stock Exchange; In 1998, the company acquired Howmedica, a major player in the orthopedic market, and doubled its size in the coming year. In 2009, the company acquired Ascent Healthcare Solutions, Inc., a leading market leader in the U.S. medical device reprocessing and remanufacturing market; In 2011, the company acquired Boston Scientific's neurovascular division, greatly expanding the brand's neurotechnology business; In 2013, the company acquired Trauson Holdings Company Limited to expand into high-value market segments in emerging markets. In the same year, the company's acquisition of MAKO Surgical Corp provided an opportunity to further promote the development of robotic arm-assisted surgery in orthopedics.
Stryker (Beijing) Medical Devices Co., Ltd.
As one of the world's cutting-edge medical technology companies, Stryker works sincerely with customers and is committed to improving healthcare. The company provides a range of innovative products and services including plastic surgery, medical and surgical equipment, neurosurgery and spine-related products to help improve the treatment experience of patients and medical institutions. Dr. Homer Stryker, an orthopedic physician in Kalamazoo, Michigan, invented a series of new products after discovering that some medical products cannot meet the needs of patients. There is growing concern and interest in these new medical products, and Dr. Stryker founded The Orthopaedic Frame Company in 1941, specializing in the production of these innovative medical products. In 1942, the company began to build wedge-shaped turnover beds, which allow caregivers to turn over patients with severe back injuries while keeping their spine fixed; In 1946, Stryker founded The Orthopaedic Frame Company; In 1979, the company issued its shares for the first time, bringing more attention to the company; in the same year, Stryker acquired Osteonics Corp. and entered the orthopedic implant market; In 1981, the company's acquisition of SynOptics provided an opportunity to expand into its endoscope business; In 1992, the acquisition of Dimso, SA opened up business opportunities in the field of spinal fixation; In 1996, the acquisition of Osteo SA provided an opportunity to enter the bone trauma market; In 1997, 18 years after the company was listed on the Nasdaq, the company was listed on the New York Stock Exchange; In 1998, the company acquired Howmedica, a major player in the orthopedic market, and doubled its size in the coming year. In 2009, the company acquired Ascent Healthcare Solutions, Inc., a leading market leader in the U.S. medical device reprocessing and remanufacturing market; In 2011, the company acquired Boston Scientific's neurovascular division, greatly expanding the brand's neurotechnology business; In 2013, the company acquired Trauson Holdings Company Limited to expand into high-value market segments in emerging markets. In the same year, the company's acquisition of MAKO Surgical Corp provided an opportunity to further promote the development of robotic arm-assisted surgery in orthopedics.
Intuitive Fosun Medical Device Technology (Shanghai) Co., Ltd.
In 2017, Fosun Pharma and US Insight Medical, a global leader in medical surgical robots, formed a joint venture in China Insight Fosun. Since its establishment, Fosun has always adhered to the core values of "patient first" and adhered to the purpose of "Made in China, joint research and development, and global sales". The company's star products, Da Vinci surgical system and Ion bronchoscopic operation control system (not available in China), have been widely recognized and used around the world as revolutionary products that guide the development of minimally invasive surgery. By empowering Chinese medical institutions and doctors, we will then allow cutting-edge minimally invasive surgical technology to benefit Chinese patients, and contribute to the innovation and development of China's medical industry with the determination of openness, inclusiveness, inclusiveness, balance and win-win. The company firmly believes that minimally invasive diagnosis and treatment technology is designed to improve the quality of life; it integrates originality and intelligent technology to provide unlimited possibilities for doctors and patients. Intuitive Fosun has always been concerned about the development trend of China's medical and health industry. With the purpose of "Made in China, joint research and development, global sales", it has deepened its roots in China and served China, and continuously introduced high-quality and effective innovative medical technologies and products to meet medical personnel and Patient needs. In July 2022, the medical robot manufacturing and R&D center of the intuitive Fosun headquarters and industrialization base project officially started construction. This is another major strategic layout after the completion of the Da Vinci Innovation Center in 2021. It marks the integration of multiple locations into a large park including production and manufacturing and innovation centers, and it is also the deepening of localization of Fosun. Another important milestone in the strategic layout.
Intuitive Fosun Medical Device Technology (Shanghai) Co., Ltd.
In 2017, Fosun Pharma and US Insight Medical, a global leader in medical surgical robots, formed a joint venture in China Insight Fosun. Since its establishment, Fosun has always adhered to the core values of "patient first" and adhered to the purpose of "Made in China, joint research and development, and global sales". The company's star products, Da Vinci surgical system and Ion bronchoscopic operation control system (not available in China), have been widely recognized and used around the world as revolutionary products that guide the development of minimally invasive surgery. By empowering Chinese medical institutions and doctors, we will then allow cutting-edge minimally invasive surgical technology to benefit Chinese patients, and contribute to the innovation and development of China's medical industry with the determination of openness, inclusiveness, inclusiveness, balance and win-win. The company firmly believes that minimally invasive diagnosis and treatment technology is designed to improve the quality of life; it integrates originality and intelligent technology to provide unlimited possibilities for doctors and patients. Intuitive Fosun has always been concerned about the development trend of China's medical and health industry. With the purpose of "Made in China, joint research and development, global sales", it has deepened its roots in China and served China, and continuously introduced high-quality and effective innovative medical technologies and products to meet medical personnel and Patient needs. In July 2022, the medical robot manufacturing and R&D center of the intuitive Fosun headquarters and industrialization base project officially started construction. This is another major strategic layout after the completion of the Da Vinci Innovation Center in 2021. It marks the integration of multiple locations into a large park including production and manufacturing and innovation centers, and it is also the deepening of localization of Fosun. Another important milestone in the strategic layout.
